🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is designed to evaluate the efficacy and safety of sintilimab-be...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04-30
Trial ID
NCT07522411
Treatments Being Tested
There is an unmet need for patients with intermediate stage hepatocellular ...
Status
Terminated
Location
Yale New Haven Hospital
Start Date
2023-06-07
Trial ID
NCT05776875
Treatments Being Tested
In the structure of malignant liver lesions, two main groups are distinguis...
Status
Unknown
Location
Central Clinical Hospital RZD-Medicine, Russian Federation
Start Date
2021-01-12
Trial ID
NCT04764409
Treatments Being Tested
Hepatocellular carcinoma (HCC) is a common global malignancy. In China, the...
Status
Active Not Recruiting
Location
Harbin Medical University Cancer Hospital, No. 150 Haping Road, Nangang District, Harbin, Heilongjiang Province, China
Start Date
2026-05-13
Trial ID
NCT07645209
Treatments Being Tested
This retrospective multicenter study aims to evaluate whether radiographic ...
Status
Completed
Location
The First Affiliated Hospital of Sun Yat-sen University
Start Date
2018-06-01
Trial ID
NCT07449065
his is a single-arm, phase II clinical study evaluating the efficacy and sa...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04-10
Trial ID
NCT07543783
This Phase II Prospective, parallel and open-label randomised control trial...
Status
Recruiting
Location
Trans Tasman Radiation Oncology Group
Start Date
2026-05-11
Trial ID
NCT07628751
Treatments Being Tested
This study is conducted to evaluate the efficacy and safety of transarteria...
Status
Unknown
Location
the Second Affiliated Hospital of Guangzhou Medical University
Start Date
2021-07-09
Trial ID
NCT04967495
This randomized phase II trial studies how well transarterial chemoemboliza...
Status
Withdrawn
Location
Multiple Locations
Start Date
2014-04
Trial ID
NCT02070419
Treatments Being Tested
To evaluate the efficacy and safety of AK104 plus lenvatinib combined with ...
Status
Active Not Recruiting
Location
The First Hospital of Beijing University
Start Date
2022-06-28
Trial ID
NCT05319431
Treatments Being Tested